Press Releases about Gilead Sciences
Gilead Sciences Announces Third Quarter 2023 Financial Results
November 07, 2023
Via Business Wire
Via Business Wire
Via Business Wire
Exposures
COVID-19
Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023
September 13, 2023
Exposures
Product Safety
Gilead Prices $2 Billion of Senior Unsecured Notes
September 07, 2023
Via Business Wire
Gilead Sciences to Present at Upcoming Investor Conferences
August 23, 2023
Via Business Wire
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|